Comparison of the Outcome and Morbidity for Localized or Locally Advanced Prostate Cancer Treated by High-dose-rate Brachytherapy Plus External Beam Radiotherapy (EBRT) Versus EBRT Alone

Abstract

The addition of HDR-BT before EBRT with a reduced dose from the EBRT produces a comparable survival outcome and GU toxicity but a significantly less GI toxicity for prostate cancer patients.